ALEXANDRIA, Va., June 17 -- United States Patent no. 12,313,613, issued on May 27, was assigned to COLVISTEC AG (Berlin).

"Method of testing crystallinity in amorphous pharmaceutical compositions" was invented by Andreas Berghaus (Berlin) and Angela Spangenberg (Georgetown, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of testing pharmaceutical compositions for the presence or absence of active pharmaceutical ingredient (API) crystallinity in an amorphous solid dispersion or solid-state solution using UV/vis spectrometry is provided. Testing may be performed standalone or during manufacturing of a pharmaceutical composition. A predictive model provides for quantitative analysis of the amount o...